Evidence-based follow-up for the patient with melanoma.
This article reviews the best evidence available to guide the follow-up of patients with melanoma, focusing on incidence of, and detection of, melanoma recurrence, frequency of follow-up visits, yield of, laboratory and radiographic tests, outcomes of patients with recurrent melanoma based on method of detection, detection of secondary melanomas, and stage-specific follow-up.
Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Ryan C
RC
Fields
Daniel G
DG
Coit
D003657:Decision Making; D018450:Disease Progression; D019317:Evidence-Based Medicine; D006801:Humans; D015994:Incidence; D008175:Lung Neoplasms / Q000473:pathology / Q000556:secondary; D008198:Lymph Nodes / Q000473:pathology; D008545:Melanoma / Q000000981:diagnostic imaging / Q000453:epidemiology* / Q000473:pathology; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D010353:Patient Education as Topic; D017060:Patient Satisfaction; D011379:Prognosis; D011859:Radiography; D012878:Skin Neoplasms / Q000000981:diagnostic imaging / Q000453:epidemiology* / Q000473:pathology; D013997:Time Factors; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology